Govt Enforces ‘Melt and Pour’ Rule for All Steel in Public Projects Nippon Steel expected to finalize U.S. Steel acquisition at $55 per share NMDC Limited reports a 38% drop in Q4 FY24 consolidated net profit RINL to Raise $23 Million Through Land Sales Amid Crisis
✅ Novartis CEO monitoring US reciprocal tariff policy’s impact.
✅ Tariffs could affect drug pricing and supply chains.
✅ Novartis prepared to adapt and minimize disruptions.
Novartis CEO Vas Narasimhan stated that the pharmaceutical giant is closely monitoring the US reciprocal tariff policy, which could impact global trade and drug pricing. Speaking at an investor conference, Narasimhan emphasized that any tariff changes could influence supply chains and operational costs.
The US government’s push for reciprocal tariffs aims to match duties imposed by other countries, potentially affecting imports and exports across multiple sectors, including pharmaceuticals. Narasimhan highlighted that Novartis is prepared to adapt to policy shifts to minimize disruptions.
Despite these concerns, Novartis remains focused on its strategic priorities and innovation pipeline. The company is also exploring measures to mitigate the financial impact of potential tariff changes.
Also Read : Trump pledges to halt Nippon's acquisition of U.S. Steel US begins to reimpose sanctions on Venezuela; oil could be the next target